Dr. Weir is an attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Medical Center. He is also a professor of medicine at the University of Maryland School of Medicine. He received his medical degree from the University of Virginia, Charlottesville and completed his residency training in medicine at the Waterbury and Yale-New Haven Hospitals in Connecticut. Later, he completed his nephrology training at the Brigham and Women's Hospital, an affiliate of Harvard Medical School in Boston, Massachusetts. He then moved to then to the University of Maryland Medical Center where he has been a full-time faculty member since 1983.
Dr. Weir's primary research interests include management and prevention of cardiovascular disease in kidney transplant patients, and developing new information technology to avoid medication errors in transplant patients. He has written more than 450 manuscripts and book chapters about these topics, and has presented at numerous international scientific association meetings, hospitals and medical schools. Dr. Weir currently reviews manuscripts for more than 20 major medical journals, and serves on the editorial board of 16 journals. He has two active NIH supported grants from NIDDK, and is a member of numerous associations, including the American Society of Nephrology, the National Kidney Foundation, the American Heart Association and the American Society of Transplantation.
Dr. Cangro has been a faculty member of the University of Maryland School of Medicine since 1996. He currently serves as the medical director of the Medical Center's post-transplant clinic. He received his medical degree from the University of Florida School of Medicine in Gainesville, where he completed fellowship training in both internal medicine and nephrology.
Dr. Cangro's special interest is managing the care of patients with diabetes both before and after transplantation. He received both his bachelor's and doctorate degrees from Georgetown University in Washington, D.C. His Ph.D. dissertation focused on the role of glutamate and N-acetyl-aspartyl-glutamate in the central nervous system. Dr. Cangro is a long-standing member of the Institutional Review Board.
Dr. Haririan is a transplant nephrologist and an attending physician on transplant medicine and general nephrology services at the University of Maryland Medical Center. He received his medical degree from Tehran University of Medical Sciences and his master of public health degree from Johns Hopkins Bloomberg School of Public Health. He completed his residency in internal medicine at Wayne State University/Detroit Medical Center, and later went on to complete fellowship training in general nephrology at Johns Hopkins Hospital and transplant nephrology at the University of Maryland Medical Center.
Before joining the Medical Center, Dr. Haririan was the medical director for the kidney and pancreas transplant programs at Harper Hospital in Detroit. He has established and is directing a weekly multidisciplinary transplant biopsy review meeting, and is the director of clinical research in transplantation in the division of nephrology. His major clinical and research interest is acute and chronic antibody-mediated graft injury. He has led efforts to establish institutional protocols for diagnosis and treatment of these important causes of graft dysfunction and graft failure. Dr. Haririan has more than 40 peer-reviewed publications in major transplant and nephrology journals. He is a reviewer for the American Journal of Transplantation, Transplantation, Transplant International and Clinical Transplantation, as well as an editorial board member for Clinical Nephrology.
Dr. Klassen is a professor of medicine at the University of Maryland School of Medicine and the medical director of the kidney and pancreas transplant programs at the University of Maryland Medical Center. He graduated cum laude from the Ohio State University College of Medicine and completed a medical residency and nephrology fellowship at the Johns Hopkins Hospital. He is a member of Phi Beta Kappa and Alpha Omega Alpha and is board certified in internal medicine and nephrology.
Dr. Klassen is an experienced transplant clinician and provides care for kidney and pancreas transplant recipients through all phases of transplantation. His research interests include clinical immunosuppression and outcomes in kidney and pancreas transplantation, the diagnosis and treatment of cellular and antibody mediated rejection in transplant recipients, immunosuppressive drug side effects, and infectious complications of transplantation. He has authored or co-authored over 80 scientific papers in transplantation and published 15 book chapters. Dr. Klassen also serves on the Membership and Professional Standards Committee of the United Network for Organ Sharing (UNOS). He is Chair of the Medical Advisory Board of the National Kidney Foundation of Maryland and Chair of the Therapeutics Committee of the University of Maryland Medical Center.
Dr. Ramos is a clinical professor of medicine at the University of Maryland School of Medicine. He is also a part-time member of the Division of Nephrology at the University of Maryland Medical Center, spending most of his time in the transplant clinic and performing surveillance biopsies. Dr. Ramos completed nephrology fellowships at both the VA Hospital in Washington, D.C., and Massachusetts General Hospital. He also completed a diabetes fellowship at the Joslin Clinic in Boston and is board certified in internal medicine and nephrology.
Dr. Ramos' special interests include clinical nephrology and diabetic nephropathy. In the past two years, he has been involved in performing post-transplant surveillance biopsies for all transplant patients at the three-month and one year mark. Early therapeutic intervention based on the results of these biopsies has been invaluable in preventing the inevitable clinical manifestation of a variety of transplant-related infections.
Dr. Ugarte is an assistant professor of medicine at the University of Maryland School of Medicine. He received his medical degree from the University of Virginia in Charlottesville in 1995, and completed his residency training in internal medicine at the Beth Israel Deaconess Medical Center. Later, Dr. Ugarte completed fellowship training in nephrology and transplant nephrology at Johns Hopkins University.
Dr. Ugarte's clinical research interests have included the use of anti-rejection Thymoglobulin induction, the use of deceased donor kidney transplants from donors with acute kidney injury and systemic inflammation as a risk factor for graft failure. His more recent interest includes understanding reasons for early kidney failure among African American kidney transplant recipients, with a focus on a particular kind of immune rejection known as chronic T-cell mediated rejection, and working with the National Institutes of Health (NIH) to look at possible genetic predispositions. Dr. Ugarte received his master's degree in health science from the Johns Hopkins Bloomberg School of Public Health.